| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/19/2011 | CA2281952C Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/14/2011 | WO2011085070A2 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts |
| 07/14/2011 | WO2011084685A2 Saposin-a derived peptides and uses thereof |
| 07/14/2011 | WO2011084523A2 Ulk1 compositions, inhibitors, screening and methods of use |
| 07/14/2011 | WO2011061625A3 Compositions for increasing polypeptide stability and activity, and related methods |
| 07/14/2011 | WO2011035067A3 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development |
| 07/14/2011 | WO2010070453A8 Meningococcal vaccines including hemoglobin receptor |
| 07/14/2011 | US20110172146 Growth hormone polypeptides and methods of making and using same |
| 07/14/2011 | US20110172115 Characterising planar samples by mass spectrometry |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171687 Unstructured recombinant polymers and compositions comprising same |
| 07/14/2011 | US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | CA2822026A1 Saposin-a derived peptides and uses thereof |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP1543039B1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 07/13/2011 | EP1178825B1 Adjuvant combination formulations |
| 07/13/2011 | CN102124029A Method of diagnosis of infection by mycobacteria and reagents therefor |
| 07/13/2011 | CN102121024A Fusion protein of human vascular endothelial growth factor 165b and human serum albumin, and preparation thereof |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120997A Method for hydrolyzing RNA by grape pathogenesis-related (PR) protein PR10-1 and improving bacteriostatic activity |
| 07/13/2011 | CN102120774A Synthesis method of artificial antigen suitable for erythrosine pigment |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120772A Chimeric antibody and immunocyte |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 07/12/2011 | US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 07/12/2011 | US7976849 Hepatitis-C virus testing |
| 07/12/2011 | US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 07/12/2011 | US7976845 Viral protein for use as tool in developing vaccines for prevention and treatment of viral infection |
| 07/12/2011 | US7976844 Fusion proteins of Mycobacterium tuberculosis |
| 07/12/2011 | US7976840 Use of anti-GL50 antibodies for the downmodulation of an immune response |
| 07/12/2011 | CA2562738C Soluble rubella e1 envelope antigens |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |
| 07/07/2011 | WO2011081904A1 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 07/07/2011 | WO2011079817A1 Dendrimer of tuftsin and influenza matrix protein，and use thereof |
| 07/07/2011 | WO2011079431A1 Fusion protein with telomerase inhibiting activity, preparation method and use thereof |
| 07/07/2011 | WO2011056911A9 Compositions and methods for enhancing production of a biological product |
| 07/07/2011 | US20110167522 Cyclin d polynucleotides, polypeptides and uses thereof |
| 07/07/2011 | US20110167521 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis |
| 07/07/2011 | US20110166323 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870 |
| 07/07/2011 | US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof |
| 07/07/2011 | US20110166062 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 07/07/2011 | US20110165674 NK-1 Receptor Mediated Delivery of Agents to Cells |
| 07/07/2011 | US20110165654 Nucleic acid modifying enzymes |
| 07/07/2011 | US20110165647 Nanoparticle conjugates |
| 07/07/2011 | US20110165623 Compositions and Methods for the High Efficiency Expression of the Transforming Growth Factor-Beta Supergene Family |
| 07/07/2011 | US20110165182 Conjugate of an antibody against ccr5 and an antifusogenic peptide |
| 07/07/2011 | US20110165180 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
| 07/06/2011 | EP2341138A1 FUSION PROTEIN COMPOSED OF MATRIX METALLOPROTEINASE-2 INHIBITOR PEPTIDE DERIVED FROM AMYLOID-beta PRECURSOR PROTEIN AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 07/06/2011 | CN102119175A Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology |
| 07/06/2011 | CN102115499A Fusion protein of antibody targeted complement regulatory factor for treating myasthenia gravis |
| 07/06/2011 | CN102115498A Connexin core sequence-containing amphiphilic polypeptide and application thereof |
| 07/06/2011 | CN102114239A Application of cell factor-super-antigen fusion protein in preparation of anti-cancer drugs |
| 07/05/2011 | US7973153 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 07/05/2011 | US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin |
| 07/05/2011 | US7973150 Reducing the immunogenicity of fusion proteins |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972830 Thermostable Taq polymerase fragment |
| 07/05/2011 | US7972603 Stable immunogenic product comprising antigenic heterocomplexes |
| 07/05/2011 | CA2488630C Immunoadhesin comprising a glycoprotein vi domain |
| 07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
| 06/30/2011 | WO2011078250A1 Radiolabeled compound directable in vivo to target tissue and use thereof |
| 06/30/2011 | WO2011077309A2 Vaccine compositions |
| 06/30/2011 | WO2011076781A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | WO2011076432A1 Chimeric polypeptides and their use in bacterial decolonization |
| 06/30/2011 | WO2011036442A3 Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders |
| 06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
| 06/30/2011 | US20110159555 Methods, Chimeric Polypeptides, Polynucleotides and Cells for Producing Bioplastics |
| 06/30/2011 | US20110159540 Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins |
| 06/30/2011 | US20110159520 Hybrid proteins comprising membrane receptor and ion channel, and their use as biosensors |
| 06/30/2011 | US20110159024 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
| 06/30/2011 | US20110158994 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |
| 06/30/2011 | CA2785585A1 Vaccine compositions |
| 06/30/2011 | CA2785139A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
| 06/29/2011 | EP2338986A1 Novel lipases and uses thereof |
| 06/29/2011 | EP2338978A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/29/2011 | EP2338916A1 Chimeric polypeptides and their use in bacterial decoloniation |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/29/2011 | EP2338510A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 06/29/2011 | EP1613661B1 Peptabody for cancer treatment |
| 06/29/2011 | EP1504036B1 Toxin-related fragments of antibodies with antimicrobial and antiviral activity |
| 06/29/2011 | EP1183348B1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112493A A polypeptide complex comprising non-peptidyl polymer having three functional ends |
| 06/29/2011 | CN102112492A Diagnosis and treatment of cancer using anti-GPR49 antibody |
| 06/29/2011 | CN101463090B Fusion protein of fibronectin and cadherin-11, preparation and use thereof |